The American Journal of Audiology (@ASHAJournals) has peer-reviewed and published the positive results of patients with bothersome #tinnitus treated with @LenireTinnitus that found 81.8% had clinically significant relief from tinnitus. Read more here: https://t.co/bQuWSx2QyE
"You can couple hearing and tinnitus. But you also have to think about uncoupling it for certain patients".
Hearing loss and tinnitus are related but not the same.
Lenire sat down with Dr. Gail Whitelaw from @OhioState Dept. of Speech and Hearing Science, one of the world's leading tinnitus experts, to unpack how closely related hearing loss and tinnitus are and how patients can direct their own care.
Watch the full episode of Talking Tinnitus below 👇
@NeuromodDevices has announced 19 new clinical partnerships to increase access to the Lenire® tinnitus treatment device for 65 million Europeans living with tinnitus. More info here, #audpeeps: https://t.co/4h9nI43llD
At @NeuromodDevices, we’re expanding the availability of @LenireTinnitus across Europe, partnering with leading hearing care professionals to bring life-changing treatment to more patients.
https://t.co/sUSKWhTmP3
The study finds 91.5% of patients experienced clinically meaningful reductions in tinnitus after 12 weeks of treatment using Lenire. https://t.co/UWeZlGxfd4
A retrospective chart review of patients with tinnitus examines the real-world outcomes of the Lenire treatment and shows that the device can be used to safely and effectively reduce tinnitus, according to a paper in @CommsMedicine. https://t.co/hHhqsf46m4
We’re honored to share this touching letter from a patient who found renewed hope and confidence through one of our dedicated partner clinics, Modern Tinnitus
After years of struggling with severe tinnitus, they discovered relief thanks to the expert care of Craig Kasper and the Modern Tinnitus team and #Lenire - the first FDA-approved bimodal neuromodulation device for tinnitus developed by Neuromod Devices.
We are proud to collaborate with partner clinics like Modern Tinnitus, who share our mission of transforming lives with evidence-based solutions, compassion, and expertise.
Stories like this inspire us every day to keep working towards a world where #tinnitus doesn’t have to hold people back from living life to the fullest—and where relief is possible.
#patientsuccessstories #audiology #Tinnitus #HearingLoss #audpeeps #soothetinnitus #neuroscience #FDAapproved #bimodalneuromodulation #Bimodal #otolaryngology
Singer songwriter, Victoria Banks, told @usatoday that she woke up one morning with #tinnitus noise that sounded like a cicada infestation. Living with high anxiety and finding it difficult to concentrate on music, Banks tried everything to get relief from constant noise.
Nothing worked. That is, until, she found Lenire.
“It (Lenire) gave me relief,” Banks said. “It gave me power over something that I didn’t have power over.” 🧘
Read @usatoday fascinating piece to learn how Lenire works, hear insights from Lenire patients and audiologists, and get an overview of the peer-reviewed real world patient results published in Nature Communications Medicine.
https://t.co/bCqWL0S3sR
#tinnitus #hearing #hearingloss #hearingcare #tinnituscare #audiologist #USAToday #audiology #AudPeeps #Aud #doctor #hearinghealth #healthcare #tinnituscare #otolaryngology #soothetinnitus #lenire
"It's been a really empowering shift in the last two years to finally have something that reliably is producing the results that we were told that it would produce with real patients."
Alaska Hearing & Tinnitus Center Owner, Emily E. McMahan, AuD, spoke with NPR's WVXU about the impact FDA Approved Lenire is having on her tinnitus patients.
Dr. McMahan is the Co-Author of the peer-reviewed real world evidence paper published by Nature Science Medicine. The paper found that 91.5 of 220 U.S. tinnitus patients had significant relief from tinnitus after 12-weeks of Lenire.
https://t.co/3bgbn71sdG
#tinnitus #tinnituscare #tinnitusrelief #hearing #hearingloss #hearingcare #earwax #audiology #audiologist #AudPeeps #FDA #otolaryngology #ENT
Nature Communications Medicine has published the positive results of 220 real world patients treated with the Lenire tinnitus treatment device.
Analysis of 220 tinnitus patients treated with Lenire at Alaska Hearing & Tinnitus Center revealed 91.5% of patients had a clinically significant reduction in tinnitus after 12-weeks of FDA Approved, Lenire.
“Fifteen percent of the global adult population experiences tinnitus, with many seeking better treatment options. These results show Lenire is successful treating tinnitus in real-world clinical settings,” said Neuromod Devices founder and CEO, Dr. Ross O'Neill
“As scientists and medical professionals, we are committed to evidence-based technology. Part of our DNA at Neuromod is working closely with a passionate network of tinnitus care experts. We train and qualify clinicians and provide ongoing support to help continuously improve clinical best practices and patient outcomes.”
The paper, Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting was co-authored by Emily E. McMahan, AuD and Neuromod Devices CSO, Prof. Hubert Lim. This is the first real world review of U.S. tinnitus patients treated with bimodal neuromodulation peer-reviewed and published by a medical journal.
You can read a summary of the paper and find a link to Nature Communications Medicine on the Lenire Blog.
https://t.co/WXSccqSffD
#tinnitus #hearingcare #hearingloss #hearing #ENT #Audiology #AuD #AuDPeeps #otolaryngology #tinnitusrelief #tinnituscare #soothetinnitus #lenire #FDAApproved #clinicallyproven #science #bimodal #neuromodulation
"As a biomedical engineer fascinated by neuroplasticity—the brain's remarkable ability to rewire itself—O'Neill first encountered the concept of sensory retraining through research on phantom limb pain..." https://t.co/eyhjwbCsXv
https://t.co/pGhVl0EKiZ
@NeuromodDevices has today announced the company has closed €10m financing to accelerate the availability of Lenire. Financing led by existing investors @fhpartners and @panakes.
“We are delighted to announce an oversubscribed financing at a pivotal time when we are driving forward with our mission of making Neuromod the category creator for tinnitus globally,” said Dr. Ross O’Neill PhD, Founder & CEO of Neuromod.
Dr. Marsha Johnson, AuD from the Oregon Tinnitus & Hyperacusis Treatment Clinic reviews @LenireTinnitus from @NeuromodDevices - find providers and read the research at https://t.co/SEkjD7Z8zk